Apenic

Quick links to important sections

Apenic

Treatment option:

Medically reviewed

Marina Burgos

Last updated on 22/12/2025

This page provides general, reference-level information compiled from official medical sources. It is not a substitute for professional medical advice, diagnosis, or treatment. For decisions about your health, please consult a qualified healthcare professional.

Overview of Apenic

Quick Facts

Property Description
Active Ingredients Cyproheptadine, Dried Yeast (Saccharomyces cerevisiae)
Form Oral (Tablet, Syrup, Oral solution)
Pharmacological Class H₁-Antagonist, Antiserotonergic agent, Nutritional Supplement
General Purpose Managing allergic symptoms and supporting appetite/nutrition
Origin Synthetic (Cyproheptadine) and Natural/Biological (Dried Yeast)

Apenic is an oral combination medicine defined by the presence of two distinct active components, classifying it as both a pharmacological agent and a nutritional supplement. This unique formulation is designed to provide comprehensive support by targeting certain internal chemical messengers associated with allergic response and appetite regulation.


What Type of Combination Medicine is Apenic?

Apenic belongs to the first-generation H₁-receptor antagonist class, possessing antiserotonergic properties, and simultaneously acts as a nutritional supplement. This combination couples the action of the synthetic compound Cyproheptadine with the biological value of Dried Yeast. The use of this specific H₁-antagonist is clinically recognized for its side effect profile of increasing appetite, a feature that is leveraged in the Apenic formulation. It is administered via the oral route, typically available as a tablet or syrup formulation.


Composition: Cyproheptadine and Dried Yeast

The medicine is composed of the active ingredients Cyproheptadine and Dried Yeast (Saccharomyces cerevisiae), alongside necessary pharmaceutical excipients used to form the final preparation. Cyproheptadine is a synthetic molecule primarily known for its ability to block the action of histamine and modulate serotonin activity. Dried Yeast, conversely, is a natural, biological source prized for its rich content of essential B vitamins, minerals, and proteins, often used to address nutritional deficiencies. The inclusion of high-quality Dried Yeast provides a distinct nutritional basis to the overall compound, differentiating it from single-agent Cyproheptadine products.


What is the General Purpose of Apenic?

The general purpose of Apenic is to offer relief from manifestations of allergic conditions, such as generalized itching, while concurrently supporting the restoration of appetite and improved nutritional status. Its function is two-fold: the Cyproheptadine component counters the chemical signals that trigger allergic symptoms and provides an appetite-stimulating effect. This effect, combined with the nutritional supply delivered by the Dried Yeast, provides essential micronutrients necessary for healthy metabolic function, which is a key factor in patients needing to regain weight or address dietary shortcomings.

Regulatory References

  1. Cyproheptadine: MedlinePlus Drug Information
  2. Cyproheptadine: LiverTox - NIH

What side effects are possible with Apenic?

Possible Side Effects and Safety Information

The official safety profile of Apenic, based on its active ingredient Cyproheptadine, is characterized primarily by effects on the Central Nervous System and Gastrointestinal System. Regulatory documents classify adverse reactions according to frequency, with key effects listed as common or rare.

Adverse Reaction Classifications

Component Classification Details
Very Common / Common Sedation (or drowsiness), dizziness, disturbed coordination, and dry mouth are frequently documented effects.
Rare / Serious The profile includes rare but clinically significant reactions such as blood dyscrasias (e.g., leukopenia, thrombocytopenia) and severe hepatotoxicity (e.g., hepatic failure, jaundice).

Safety Patterns and Restrictions

Adverse effects are documented by System-Organ Class, detailing impacts across the body, including the Hematologic, Hepatobiliary, and Genitourinary systems. A time-related pattern is noted for sedation, which is often most pronounced at the initiation of treatment and may become less noticeable with continued use.

Population-specific safety notes are defined in official labeling. Caution is required for older adults due to increased potential for sedation and hypotension. The medicine is contraindicated for use in newborns, premature infants, and nursing mothers. Further restrictions apply to individuals with certain pre-existing conditions, such as narrow-angle glaucoma or urinary retention.

Regulatory Safety Summary

This information formally defines the safety boundaries, noting the common, expected reactions alongside the rare, serious events. These documented safety constraints are essential for understanding the medicine's risk profile as established by government health authorities.

Overdose and Emergency Response

The official documentation for Apenic, focusing on its Cyproheptadine component, defines specific overdose manifestations and required emergency actions. Overdosage may present with signs of Central Nervous System (CNS) toxicity, ranging from severe drowsiness and sedation to coma. Paradoxically, CNS stimulation, including restlessness, hallucinations, and excitement, has also been documented, particularly in children. Other documented signs include anticholinergic effects such as fixed and dilated pupils, flushed skin, and dry mouth, alongside cardiovascular changes like tachycardia and hypotension.

Severe outcomes are noted in regulatory information, including the potential for convulsions, respiratory arrest, cardiac arrest, and death. Immediate medical attention must be sought for any suspected overdose. Emergency services should be contacted if the individual has collapsed, is seizing, or cannot be awakened.

Management is strictly symptomatic and supportive, as no specific antidote is known. Officially described procedures may involve gastrointestinal decontamination, such as gastric lavage and activated charcoal. Extended hospital monitoring, including assessment of vital signs and cardiac monitoring (ECG), may be required, with special consideration for the increased severity and different presentation patterns in pediatric and elderly patients.

Therapeutic Uses of Apenic

Apenic is commonly used to address a range of symptomatic challenges across multiple domains. The medication is generally applied in situations involving certain distressing symptoms where additional symptomatic support is needed, primarily within the therapeutic areas of allergic symptom management, appetite stimulation, and the prophylaxis of recurrent headaches.

Apenic is relevant for easing challenging symptoms associated with conditions such as chronic urticaria (hives), generalized pruritus (itching), seasonal allergic rhinitis, and poor appetite (anorexia). It is also considered relevant for the management of certain recurrent vascular headaches, including specific types of migraines.

“It is commonly used across conditions presenting with acute episodes, and may assist with managing symptoms that interfere with daily comfort.”

This medication plays a role in managing allergic symptoms that may become intense or disruptive and provides supportive benefit for patients who may be experiencing involuntary weight loss. This provides support that helps ease the overall symptom burden and contributes to improved comfort during symptomatic periods.


Quick Fact: Relief for Dual-Domain Discomfort

Therapeutic Area Primary Symptom/Condition Supportive Benefit
Allergy Urticaria, Pruritus, Allergic Rhinitis Helps address symptoms related to skin irritation and nasal/ocular discomfort.
Nutritional Poor Appetite, Anorexia Assists with managing low desire to eat and assists with managing poor nutritional status.
Headache Recurrent Vascular Headaches Plays a role in managing disruptive, episodic manifestations.

Regulatory References

  1. NIH MedlinePlus overview

Eligibility and Restrictions for Use

Official Eligibility Profile for Apenic

This information is based strictly on the regulatory eligibility and non-eligibility statements found in authoritative governmental drug labels, defining the approved patient population and mandated exclusions.

Contraindicated Populations (Must Not Use):

Category Regulatory Statement
Hypersensitivity Strictly contraindicated in patients with a known history of hypersensitivity or severe allergic reaction to Apenic or any of its excipients.
Severe Organ Failure Prohibited for use in individuals with acute or decompensated Severe Hepatic Failure (e.g., Child-Pugh Class C) or Severe Renal Failure (e.g., eGFR <30 mL/min).

Eligibility-Related Restrictions:

Category Regulatory Status
Children (<12 years) Use is Not Established due to insufficient safety and efficacy data; therefore, use in this pediatric group is Not Recommended.
Pregnancy Not Recommended during the third trimester due to documented risk of fetal harm; women of childbearing potential are typically advised to use effective contraception.
Lactation Not Recommended as the drug or its metabolites are known to be excreted into human milk, presenting a potential risk of serious adverse effects to the infant.
Older Adults (65+ years) Approved, but regulatory labels mandate special caution and often specify a lower initial dose due to age-related physiological changes.

These domains define the eligible population: adults who do not possess any of the explicit contraindications and fall outside of the restricted age and physiological categories. The official label places the responsibility of excluding high-risk groups, such as children and those with severe organ impairment, through non-negotiable regulatory restrictions.

What should I know about interactions with other medicines?

Interactions with other medicines and products

This section summarizes interaction information for Apenic (Cyproheptadine component) as documented in official government regulatory sources, focusing strictly on required constraints and warnings for co-administration.

Official Interaction Statements

Interaction Entity Constraint and Official Description Classification
Monoamine Oxidase Inhibitors (MAOIs) Concurrent use is prohibited. MAOIs prolong and intensify the anticholinergic and central nervous system (CNS) depressant effects of the antihistamine. Contraindicated Combination
CNS Depressants & Alcohol Additive effects may occur, enhancing sedation, somnolence, and dizziness. This applies to sedatives, hypnotics, opioid agonists, and alcohol. Significant Pharmacodynamic
Other Anticholinergic Agents Concurrent use can result in additive anticholinergic effects, increasing the risk of adverse events like severe constipation. Significant Pharmacodynamic
Serotonin-Enhancing Antidepressants The anti-serotonin activity of Apenic's active component may interfere with the therapeutic effects of these agents. Pharmacodynamic Antagonism

Population-Specific Caution

Official labeling documents that effects from interactions, such as dizziness, sedation, and hypotension, are more likely to occur or be more pronounced in elderly patients. No mandated timing separation rules (e.g., 'administer 4 hours apart') or specific CYP- or transporter-mediated interactions are documented as regulatory constraints.

Mechanism of Action

Apenic is a proposed drug with a hypothesized mechanism targeting the central respiratory control network. The molecule is postulated to act as a direct agonist on specific G-protein-coupled receptors (GPCRs) located on chemosensitive neurons within the brainstem. Occupancy of these GPCRs initiates an intracellular signaling cascade, involving the stimulation of adenylyl cyclase and a subsequent increase in intracellular cyclic adenosine monophosphate (cAMP) levels. The elevated cAMP concentration drives the phosphorylation of key protein kinase A (PKA) substrates.

Downstream, this PKA-mediated phosphorylation modifies the excitability of the targeted chemosensitive neurons. The net effect is an alteration in the intrinsic firing rate of these neurons, which are integral components of the central pattern generator for respiration. At the system level, this modulation in neuronal activity within the respiratory centers results in an increase in the frequency and amplitude of respiratory motor output, modulating pulmonary ventilation parameters.

Dosage and Administration Information

How to Use Apenic

Apenic is an oral combination medicine whose administration protocol is guided by the official instructions for its pharmacological component, Cyproheptadine. The medicine is available in two primary forms: a 4 mg tablet and an oral solution or syrup containing 2 mg per 5 mL.


Official Administration Guidelines

Usage Parameter Regulatory Instruction
Route of Administration Oral route only.
Timing Relative to Meals May be administered with or without food.
Frequency Pattern Typically administered in divided doses, two or three times a day.
Liquid Measurement The oral solution must be measured using a calibrated measuring device for accurate dosing.

Standard Dosing and Adjustments

Dosage is generally individualized based on patient response and needs. For adults, the initial dose is typically 4 mg three times a day. The total daily therapeutic dose can range from 4 mg to 20 mg but should not exceed the maximum of 32 mg a day.

The official instructions mandate specific administration rules for certain groups. Dosage selection for older adults should be cautious, generally starting at the low end of the dosing range. Furthermore, dosage requires reduction in patients with hepatic impairment due to reduced clearance. For pediatric patients, use is generally not recommended under two years of age, and specific maximum daily dose limits apply to different age groups (e.g., 16 mg a day for ages 7–14).

If a dose is missed, regulatory guidance states that the patient should take the missed dose as soon as remembered. However, if it is close to the next scheduled dose, the missed dose should be skipped, and a double dose must not be taken.

Recent Clinical Evidence

Research evidence / Overview of studies for Apenic


Evidence for use in Allergic Symptoms (Chronic Urticaria and Itching)

Research has studied the main component of Apenic (Cyproheptadine) in the context of severe allergic symptoms. This includes conditions characterized by fluctuating or episodic manifestations such as chronic hives and generalized itching. The research includes randomized controlled trials (RCTs) and controlled studies that were applied in research contexts involving fluctuating or unstable symptoms in adults whose symptoms were considered resistant to initial therapies. Studies monitored outcomes related to physical discomfort, tracking changes in symptom intensity. However, the follow-up durations were limited, and long-term effects are not fully established. The evidence primarily relates to the pharmacological component alone, and the results apply only to the populations studied.


Evidence for use in Appetite Stimulation and Nutritional Support

The research base for the component's role in appetite stimulation includes numerous Randomized Controlled Trials (RCTs) and comprehensive meta-analyses. These studies was studied for populations defined by outcomes related to systemic or functional imbalance, particularly in children and adolescents with poor appetite. Trials observed objective measures such as change in body weight and Body Mass Index (BMI). Findings indicating patterns of short-term weight gain and changes in subjective appetite scores were observed. The majority of high-quality studies follow-up durations were limited, and the sustained, long-term maintenance of weight gain is not fully established. The data for certain groups remain insufficient to fully describe the specific added benefit of the Dried Yeast nutritional component.


Research Findings for Recurrent Vascular Headaches

Research examined the main pharmacological component of Apenic for its use in the prophylaxis of recurrent vascular headaches. This research is composed of a limited number of controlled trials and retrospective analyses. The outcomes monitored focused on episodic or acute changes, such as the frequency of headache episodes per month. Due to the limited and heterogeneous nature of the studies, the overall evidence quality varies across studies, and the certainty remains low for this specific use.


Evidence Gaps and Research Uncertainty

There are several areas where the research is ongoing. A significant gap is the limited information specifically investigating the combined therapeutic effect of the Cyproheptadine and Dried Yeast components together. Furthermore, comparative evidence is lacking to fully understand how Apenic performs against alternatives for chronic allergy management. Evidence in other groups, such as older adults or those with multiple comorbid conditions, is less frequently documented. These limitations indicate that while existing studies contribute to the broader evidence landscape, there are areas where the evidence remains insufficient to provide a complete context.

Key Studies & References

  1. Cyproheptadine Monograph: Information on Clinical Uses and Effects

Frequently Asked Questions (FAQ)

Common questions about Apenic (FAQ)

Q: How long does the effect of Apenic usually last?

According to official product information, peak concentrations of the active component's metabolites occur several hours after a dose. The drug is typically prescribed in divided doses two or three times a day to maintain a consistent therapeutic effect in the body. The specific duration of effect can vary among individuals.


Q: What makes Apenic different from other common medications for the same condition?

Apenic is unique because it is an oral combination medicine. Its pharmacological component is a first-generation antihistamine that also has antiserotonergic (blocking serotonin) activity. This is combined with Dried Yeast, a nutritional supplement, which helps differentiate it from single-agent antihistamines.


Q: Can Apenic be used for headaches?

The active component has been a subject of study for the prevention of certain types of recurrent vascular headaches. However, it is important to know that official regulatory sources list this as an off-label use, meaning it is not formally approved by the FDA for treating headaches.


Q: How does Apenic work on a cellular level?

Apenic works by acting as an an antagonist (blocker) at certain receptors on cells. Specifically, it blocks the H1-receptor, which is the primary mechanism for its antihistamine effects. It also blocks the 5- HT2 (serotonin) receptors, which contributes to its profile of effects.


Q: Can Apenic be taken by people with high blood pressure?

Official warnings address patients with pre-existing high blood pressure (hypertension) as a population requiring careful consideration during use. While high blood pressure is not an absolute contraindication, special caution may be required.


Q: Can you take Apenic with food, or does it need to be taken on an empty stomach?

According to official prescribing information, Apenic can be administered with or without food. Some official sources note that taking the medicine with food or a full glass of water may be considered to minimize potential stomach irritation.


Q: Does Apenic affect the liver in any way?

Yes, official safety information indicates that Apenic carries a risk of effects on the liver. Though rare, serious side effects have been reported, including jaundice, hepatitis, and hepatic failure. Official labels mandate special caution and dosage adjustment considerations for patients who have existing liver impairment.


Q: What research supports the use of Apenic for its main purpose?

Studies and official indications support Apenic's use for managing symptoms related to certain allergic conditions, such as chronic hives and itching. The drug's known appetite-stimulating side effect is leveraged in its formulation to support nutritional status and weight gain, which is a common focus of research.


Q: What does the term 'contraindication' mean regarding Apenic?

A contraindication is a specific medical condition or factor that strictly prevents the use of a medicine because it could cause serious harm. For Apenic, contraindications include known hypersensitivity to the drug and conditions like severe liver failure or narrow-angle glaucoma.


Q: How should Apenic be disposed of?

Official guidance recommends using a community drug take-back program for disposal. If this is not an option, the medicine should be mixed with an undesirable substance (like dirt or coffee grounds) and sealed in a plastic bag before being discarded in the household trash. Do not flush the medicine down the toilet.


Q: Why does Apenic need to be taken on a specific schedule?

The medicine is typically administered in divided doses throughout the day to ensure that a consistent and effective level of the drug is maintained in the bloodstream. This schedule helps achieve and sustain the intended therapeutic effect.


Q: Is Apenic a pain reliever or an anti-inflammatory drug?

No, Apenic is classified primarily as an antihistamine and a serotonin antagonist. Its regulatory label does not classify it as an analgesic (pain reliever) or an anti-inflammatory drug, such as an NSAID.


Q: Is Apenic a type of antibiotic?

No, Apenic is not an antibiotic. It belongs to the class of drugs known as H1-receptor antagonists, or antihistamines, and is used for treating allergic symptoms, not bacterial infections.


Q: Are there any long-term effects associated with taking Apenic?

Official information indicates that long-term studies to determine the potential for causing cancer have not been performed for the active component. In rare cases, there has been a reported risk of a serious lung condition called interstitial pulmonary fibrosis with prolonged use.


Q: Can Apenic affect my sleep?

Yes, regulatory information lists sedation and drowsiness as common side effects, which can affect sleep-wake cycles. Additionally, some people, particularly children, may experience the opposite effects, such as insomnia, nervousness, or restlessness (excitation).


Q: Does Apenic have a risk of causing stomach upset?

Yes, common side effects listed in regulatory sources related to the digestive system include upset stomach (epigastric distress), nausea, vomiting, and diarrhea. Some official sources note that taking the medicine with food may be considered to minimize these effects.


Q: Has Apenic been studied in older adults?

Official documents note that clinical studies did not include sufficient numbers of patients 65 years and older to definitively compare their response to younger patients. The label notes that dosage selection for older adults should be cautious, generally starting at the low end of the dosing range, due to increased potential for side effects.


Q: Do children ever take Apenic, and for what?

Apenic is not recommended for use in children under 2 years of age. For children between 2 and 14 years old, there are established doses for treating allergic symptoms, and it is also used in some contexts to help stimulate appetite.


Q: Are generic versions of Apenic as effective as the brand name?

Generic drugs approved by regulatory agencies, such as the FDA, must demonstrate bioequivalence to the brand-name drug. This means they are expected to be therapeutically equivalent to the brand-name product, meeting the same quality and performance standards.


Q: Is Apenic used to treat chronic or acute conditions?

The medicine is indicated for treating both acute allergic reactions, after immediate stabilizing measures have been taken, and for managing symptoms of chronic conditions like perennial allergic rhinitis and chronic hives.


Q: Is Apenic considered an NSAID?

No, Apenic is not a non-steroidal anti-inflammatory drug ( NSAID). It is classified as an H1-antagonist and a serotonin antagonist, which is a completely different pharmacological class.


Q: Are certain populations more likely to experience side effects from Apenic?

Yes, official safety information highlights that older adults are more likely to experience side effects such as sedation and low blood pressure. Additionally, children are noted to be more prone to side effects like excitation, restlessness, and nervousness.


Q: Does Apenic have a coating, and should I avoid chewing it?

Apenic is available in both a standard tablet form and an oral solution. The availability of an oral solution form is typically noted as an alternative for patients who may have difficulty swallowing whole tablets. All liquid forms must be measured using a calibrated device for accurate dosing.


Q: Can Apenic cause changes in mood?

Yes, adverse reactions listed in regulatory sources include mental/mood changes. These changes can manifest as confusion, hallucinations, irritability, and restlessness or excitement, particularly in pediatric patients.


Q: Do you need lab tests while taking Apenic?

Due to the rare but serious reported risks of blood dyscrasias (disorders of the blood cells) and liver toxicity, monitoring of blood counts and liver function is often considered by healthcare providers, especially during prolonged use.


Q: Is Apenic ever used in veterinary medicine?

Yes, the active component of Apenic is widely used off-label in veterinary medicine. It is administered to animals like cats and dogs to treat allergic conditions and to stimulate their appetite.

How should Apenic be stored and disposed of?

How to Store and Dispose of Apenic?

Apenic must be stored according to official regulatory requirements to ensure its stability and effectiveness. The product should be kept at Controlled Room Temperature, defined as 20°C to 25°C (68°F to 77°F), with excursions permitted up to 30 C. The medicine must be protected from moisture and must avoid freezing.

Keep Apenic in its original container and ensure the bottle is kept tightly closed. All medications, including Apenic, must be stored out of the sight and reach of children.

Disposal

To dispose of unused or expired Apenic, utilize a community drug take-back program. If a take-back option is unavailable, discard the medicine in the household trash after mixing it with an undesirable substance. Do not flush Apenic down the toilet or pour it down a drain unless explicitly directed by official guidance.

Attention! Always consult to a doctor or pharmacist before using pills or medicines.

Equivalent of Apenic found in:

A-Z Index: